Level Four Advisory Services’s Transmedics TMDX Stock Holding History

Level Four Advisory Services’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,117	Closed	-$483K	–	888
2024 Q1	$483K	Buy	6,117 +148	+2%	+$12.2K	0.03%	481
2023 Q4	$471K	Buy	+5,969	New	+$360K	0.03%	488

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Level Four Advisory Services's TMDX Position: Q2 2024 in Review

Level Four Advisory Services sold out of Transmedics (TMDX) in Q2 2024, closing a stake of 6,117 shares — an estimated $483K sold.

Level Four Advisory Services first reported a position in TMDX in Q4 2023 and held it in 2 quarters. The position peaked at $483K in Q1 2024. 340 funds tracked by Wall St. Rank hold TMDX as of Q2 2024.

Level Four Advisory Services reported no remaining Transmedics position as of Q2 2024 after selling out during the quarter.
Level Four Advisory Services sold 6,117 Transmedics shares in Q2 2024, an estimated $483K.
Level Four Advisory Services first reported a position in Transmedics in Q4 2023 and held it in 2 quarters.
Level Four Advisory Services's Transmedics position peaked at $483K in Q1 2024.
340 funds tracked by Wall St. Rank held Transmedics as of Q2 2024.

Based on Level Four Advisory Services's 13F filing for Q2 2024, filed 9 Aug 2024.